BCL2 and colorectal carcinoma: We conjectured that the downregulated BCL2 expression in WHSC1-KD CRC cells probably lead to the lack of synergistic effect on BCL2-specific inhibitors, or to some extent, it was due to the fact that WHSC1 and venetoclax targeted the same molecule.